In the August 15, 2011, issue of Fortune, the story “Inside Pfizer’s palace coup” provided a detailed account of the ouster of Jeff Kindler, CEO of Pfizer Inc. until December 2010. Some watchers of Pfizer’s R&D efforts are victims of several “brutal layoffs” within the company. Others are pharma outsiders who debated with management as to whether there actually was a “Pfizer model of drug discovery” and, if so, the advisability of trying to emulate it. The description of Pfizer as a “dysfunctional pharmaceutical giant” and the drama and politics of Kindler’s ouster came as confirmation that Pfizer was no...